SCHEMBL8302677

SCHEMBL8302677

Brc1c(NC2=NCCN2)ccc2cn[nH]c12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 17/20 0.58
ADRA2B P18089 17/20 0.58
ADRA2C P18825 17/20 0.58
ADRA1D P25100 13/20 0.58
ADRA1B P35368 12/20 0.58
ADRA1A P35348 11/20 0.58
KDM4E B2RXH2 1/20 0.53
NR1I2 O75469 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
HTR1A P08908 1/20 0.53
CYP2D6 P10635 1/20 0.53
MAPT P10636 1/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 1/20 0.53
MAPK1 P28482 1/20 0.53
BLM P54132 1/20 0.53
HSD17B10 Q99714 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6968281 0.84 ADRA2A (0.58) ADRA2AADRA2BADRA2CADRA1DADRA1B
Hydrochloric Acid SCHEMBL6977239 0.83 ADRA2A (0.56) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL3658622 0.81 ADRA2A (0.52) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL6964831 0.81 ADRA2A (0.45) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL11210624 0.74 ADRA2A (0.61) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL7027501 0.74 ADRA2A (0.61) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL7025906 0.74 ADRA2A (0.55) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL7759458 0.73 ADRA2A (1.00) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL2215762 0.73 ADRA2A (0.64) ADRA2AADRA2BADRA2CADRA1DADRA1B
SCHEMBL7676389 0.73 HTR1D (0.49) ADRA2AADRA2BADRA2CADRA1DADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1244864-A 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists PROCTER & GAMBLE (US) 2000-02-16 CN claimed
EP-0944620-A1 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1999-09-29 EP claimed
WO-1998023609-A1 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1998-06-04 WO claimed
CN-1244864-A 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists PROCTER & GAMBLE (US) 2000-02-16 CN disclosed
CN-1244864-A 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists PROCTER & GAMBLE (US) 2000-02-16 CN disclosed
EP-0944620-A1 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1999-09-29 EP disclosed
EP-0944620-A1 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1999-09-29 EP disclosed
WO-1998023609-A1 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1998-06-04 WO disclosed
WO-1998023609-A1 2-IMIDAZOLINYLAMINOINDAZOLE COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS THE PROCTER & GAMBLE COMPANY (US) 1998-06-04 WO disclosed